Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.

Hdl Handle:
http://hdl.handle.net/10147/575135
Title:
Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.
Authors:
Horton, Amanda L; Lai, Yinglei; Rouse, Dwight J; Spong, Catherine Y; Leveno, Kenneth J; Varner, Michael W; Mercer, Brian M; Iams, Jay D; Wapner, Ronald J; Sorokin, Yoram; Thorp, John M; Ramin, Susan M; Malone, Fergal D; O'Sullivan, Mary J; Hankins, Gary D V; Caritis, Steve N
Affiliation:
Rotunda Hospital
Citation:
Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes. 2015, 32 (4):387-92 Am J Perinatol
Journal:
American Journal of Perinatology
Issue Date:
Mar-2015
URI:
http://hdl.handle.net/10147/575135
DOI:
10.1055/s-0034-1387930
PubMed ID:
25241107
Abstract:
This study aims to evaluate whether magnesium sulfate administration for neuroprotection prolongs latency in women with preterm premature rupture of membranes (PPROM) between 24 and 31(6/7) weeks' gestation.
Item Type:
Article
Language:
en
Keywords:
Magnesium Sulphate; Latency; Preterm; Premature Rupture of Membranes; PREGNANCY
ISSN:
1098-8785

Full metadata record

DC FieldValue Language
dc.contributor.authorHorton, Amanda Len
dc.contributor.authorLai, Yingleien
dc.contributor.authorRouse, Dwight Jen
dc.contributor.authorSpong, Catherine Yen
dc.contributor.authorLeveno, Kenneth Jen
dc.contributor.authorVarner, Michael Wen
dc.contributor.authorMercer, Brian Men
dc.contributor.authorIams, Jay Den
dc.contributor.authorWapner, Ronald Jen
dc.contributor.authorSorokin, Yoramen
dc.contributor.authorThorp, John Men
dc.contributor.authorRamin, Susan Men
dc.contributor.authorMalone, Fergal Den
dc.contributor.authorO'Sullivan, Mary Jen
dc.contributor.authorHankins, Gary D Ven
dc.contributor.authorCaritis, Steve Nen
dc.date.accessioned2015-08-18T14:42:26Zen
dc.date.available2015-08-18T14:42:26Zen
dc.date.issued2015-03en
dc.identifier.citationEffect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes. 2015, 32 (4):387-92 Am J Perinatolen
dc.identifier.issn1098-8785en
dc.identifier.pmid25241107en
dc.identifier.doi10.1055/s-0034-1387930en
dc.identifier.urihttp://hdl.handle.net/10147/575135en
dc.description.abstractThis study aims to evaluate whether magnesium sulfate administration for neuroprotection prolongs latency in women with preterm premature rupture of membranes (PPROM) between 24 and 31(6/7) weeks' gestation.en
dc.language.isoenen
dc.rightsArchived with thanks to American journal of perinatologyen
dc.subjectMagnesium Sulphateen
dc.subjectLatencyen
dc.subjectPretermen
dc.subjectPremature Rupture of Membranesen
dc.subjectPREGNANCYen
dc.titleEffect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.en
dc.typeArticleen
dc.contributor.departmentRotunda Hospitalen
dc.identifier.journalAmerican Journal of Perinatologyen
dc.description.fundingOtheren
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.